Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Using Nanobodies to Study Protein Function in Developing Organisms.

Aguilar G, Matsuda S, Vigano MA, Affolter M.

Antibodies (Basel). 2019 Feb 12;8(1). pii: E16. doi: 10.3390/antib8010016. Review.

2.

Reflections on the use of protein binders to study protein function in developmental biology.

Aguilar G, Vigano MA, Affolter M, Matsuda S.

Wiley Interdiscip Rev Dev Biol. 2019 Nov;8(6):e356. doi: 10.1002/wdev.356. Epub 2019 Jul 2. Review.

PMID:
31265212
3.

Correction: DARPins recognizing mTFP1 as novel reagents for in vitro and in vivo protein manipulations (doi:10.1242/bio.036749).

Vigano MA, Bieli D, Schaefer JV, Jakob RP, Matsuda S, Maier T, Plückthun A, Affolter M.

Biol Open. 2018 Dec 13;7(12). pii: bio040832. doi: 10.1242/bio.040832. No abstract available.

4.

DARPins recognizing mTFP1 as novel reagents for in vitro and in vivo protein manipulations.

Vigano MA, Bieli D, Schaefer JV, Jakob RP, Matsuda S, Maier T, Plückthun A, Affolter M.

Biol Open. 2018 Oct 29;7(11). pii: bio036749. doi: 10.1242/bio.036749. Erratum in: Biol Open. 2018 Dec 13;7(12):.

5.

A bacterial type III secretion-based protein delivery tool for broad applications in cell biology.

Ittig SJ, Schmutz C, Kasper CA, Amstutz M, Schmidt A, Sauteur L, Vigano MA, Low SH, Affolter M, Cornelis GR, Nigg EA, Arrieumerlou C.

J Cell Biol. 2015 Nov 23;211(4):913-31. doi: 10.1083/jcb.201502074.

6.

An epigenetic profile of early T-cell development from multipotent progenitors to committed T-cell descendants.

Vigano MA, Ivanek R, Balwierz P, Berninger P, van Nimwegen E, Karjalainen K, Rolink A.

Eur J Immunol. 2014 Apr;44(4):1181-93. doi: 10.1002/eji.201344022. Epub 2014 Feb 1.

7.

Large scale RNAi screen reveals that the inhibitor of DNA binding 2 (ID2) protein is repressed by p53 family member p63 and functions in human keratinocyte differentiation.

Wu N, Castel D, Debily MA, Vigano MA, Alibert O, Mantovani R, Iljin K, Romeo PH, Gidrol X.

J Biol Chem. 2011 Jun 10;286(23):20870-9. doi: 10.1074/jbc.M110.169433. Epub 2011 Apr 10.

8.

C/EBPδ gene targets in human keratinocytes.

Borrelli S, Fanoni D, Dolfini D, Alotto D, Ravo M, Grober OM, Weisz A, Castagnoli C, Berti E, Vigano MA, Mantovani R.

PLoS One. 2010 Nov 2;5(11):e13789. doi: 10.1371/journal.pone.0013789.

9.

Mutant p53 subverts p63 control over KLF4 expression in keratinocytes.

Cordani N, Pozzi S, Martynova E, Fanoni D, Borrelli S, Alotto D, Castagnoli C, Berti E, Viganò MA, Mantovani R.

Oncogene. 2011 Feb 24;30(8):922-32. doi: 10.1038/onc.2010.474. Epub 2010 Oct 25.

PMID:
20972454
10.

The p63 target HBP1 is required for skin differentiation and stratification.

Borrelli S, Candi E, Hu B, Dolfini D, Ravo M, Grober OM, Weisz A, Dotto GP, Melino G, Viganò MA, Mantovani R.

Cell Death Differ. 2010 Dec;17(12):1896-907. doi: 10.1038/cdd.2010.59. Epub 2010 Jun 4.

11.

Transcriptional network of p63 in human keratinocytes.

Pozzi S, Zambelli F, Merico D, Pavesi G, Robert A, Maltère P, Gidrol X, Mantovani R, Vigano MA.

PLoS One. 2009;4(3):e5008. doi: 10.1371/journal.pone.0005008. Epub 2009 Mar 25.

12.

p63 regulates the caspase-8-FLIP apoptotic pathway in epidermis.

Borrelli S, Candi E, Alotto D, Castagnoli C, Melino G, Viganò MA, Mantovani R.

Cell Death Differ. 2009 Feb;16(2):253-63. doi: 10.1038/cdd.2008.147. Epub 2008 Oct 17.

13.

Hoxd13 binds in vivo and regulates the expression of genes acting in key pathways for early limb and skeletal patterning.

Salsi V, Vigano MA, Cocchiarella F, Mantovani R, Zappavigna V.

Dev Biol. 2008 May 15;317(2):497-507. doi: 10.1016/j.ydbio.2008.02.048. Epub 2008 Mar 8.

14.

Breast cancer metastases are molecularly distinct from their primary tumors.

Vecchi M, Confalonieri S, Nuciforo P, Viganò MA, Capra M, Bianchi M, Nicosia D, Bianchi F, Galimberti V, Viale G, Palermo G, Riccardi A, Campanini R, Daidone MG, Pierotti MA, Pece S, Di Fiore PP.

Oncogene. 2008 Apr 3;27(15):2148-58. Epub 2007 Oct 22.

PMID:
17952122
15.

Hitting the numbers: the emerging network of p63 targets.

Viganò MA, Mantovani R.

Cell Cycle. 2007 Feb 1;6(3):233-9. Epub 2007 Feb 3. Review.

PMID:
17297297
16.

Identification of new p63 targets in human keratinocytes.

Testoni B, Borrelli S, Tenedini E, Alotto D, Castagnoli C, Piccolo S, Tagliafico E, Ferrari S, Viganò MA, Mantovani R.

Cell Cycle. 2006 Dec;5(23):2805-11. Epub 2006 Dec 1.

PMID:
17172858
17.

New p63 targets in keratinocytes identified by a genome-wide approach.

Viganò MA, Lamartine J, Testoni B, Merico D, Alotto D, Castagnoli C, Robert A, Candi E, Melino G, Gidrol X, Mantovani R.

EMBO J. 2006 Nov 1;25(21):5105-16. Epub 2006 Oct 12.

18.

Repression of new p53 targets revealed by ChIP on chip experiments.

Ceribelli M, Alcalay M, Viganò MA, Mantovani R.

Cell Cycle. 2006 May;5(10):1102-10. Epub 2006 May 15.

PMID:
16721047
19.

Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters.

Testa A, Donati G, Yan P, Romani F, Huang TH, Viganò MA, Mantovani R.

J Biol Chem. 2005 Apr 8;280(14):13606-15. Epub 2005 Jan 11.

20.

Conserved regulation of the Caenorhabditis elegans labial/Hox1 gene ceh-13.

Streit A, Kohler R, Marty T, Belfiore M, Takacs-Vellai K, Vigano MA, Schnabel R, Affolter M, Müller F.

Dev Biol. 2002 Feb 15;242(2):96-108.

21.

A HOX complex, a repressor element and a 50 bp sequence confer regional specificity to a DPP-responsive enhancer.

Marty T, Vigano MA, Ribeiro C, Nussbaumer U, Grieder NC, Affolter M.

Development. 2001 Jul;128(14):2833-45.

22.

Nuclear interpretation of Dpp signaling in Drosophila.

Affolter M, Marty T, Vigano MA, Jaźwińska A.

EMBO J. 2001 Jul 2;20(13):3298-305. Review.

23.

Direct transcriptional control of the Dpp target omb by the DNA binding protein Brinker.

Sivasankaran R, Vigano MA, Müller B, Affolter M, Basler K.

EMBO J. 2000 Nov 15;19(22):6162-72.

24.

Balancing import and export in development.

Affolter M, Marty T, Vigano MA.

Genes Dev. 1999 Apr 15;13(8):913-5. Review. No abstract available.

25.

Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-binding context.

Viganò MA, Di Rocco G, Zappavigna V, Mavilio F.

Mol Cell Biol. 1998 Nov;18(11):6201-12.

27.

Regulation of the human HOXD4 gene by retinoids.

Moroni MC, Viganó MA, Mavilio F.

Mech Dev. 1993 Dec;44(2-3):139-54.

PMID:
7908827
28.

A novel N-terminal motif for palmitoylation of G-protein alpha subunits.

Parenti M, Viganó MA, Newman CM, Milligan G, Magee AI.

Biochem J. 1993 Apr 15;291 ( Pt 2):349-53.

29.

Oct-3 and mammalian development: correction of discussion.

Rosner MH, Vigano MA, Rigby PW, Arnheiter H, Staudt LM.

Science. 1992 Jul 10;257(5067):147.

PMID:
1631538
30.

Oct-3 and the beginning of mammalian development.

Rosner MH, Vigano MA, Rigby PW, Arnheiter H, Staudt LM.

Science. 1991 Jul 12;253(5016):144-5. No abstract available.

PMID:
1853199
31.

Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3-related sequences dispersed in the mouse genome.

Siracusa LD, Rosner MH, Vigano MA, Gilbert DJ, Staudt LM, Copeland NG, Jenkins NA.

Genomics. 1991 Jun;10(2):313-26.

PMID:
1676977
32.

A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.

Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, Staudt LM.

Nature. 1990 Jun 21;345(6277):686-92.

PMID:
1972777
33.
34.

Energy-related neurotoxicity at the NMDA receptor: a possible role in Alzheimer's disease and related disorders.

Henneberry RC, Novelli A, Vigano MA, Reilly JA, Cox JA, Lysko PG.

Prog Clin Biol Res. 1989;317:143-56.

PMID:
2481321
35.

Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.

Giraldo E, Viganò MA, Hammer R, Ladinsky H.

Mol Pharmacol. 1988 Jun;33(6):617-25.

PMID:
3380078
36.

Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.

Giraldo E, Micheletti R, Montagna E, Giachetti A, Viganò MA, Ladinsky H, Melchiorre C.

J Pharmacol Exp Ther. 1988 Mar;244(3):1016-20.

PMID:
3252019
37.

Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116.

Ladinsky H, Giraldo E, Monferini E, Schiavi GB, Viganò MA, De Conti L, Micheletti R, Hammer R.

Trends Pharmacol Sci. 1988 Feb;Suppl:44-8. Review. No abstract available.

PMID:
3074536
38.

Characterization of muscarinic receptor subtypes in human tissues.

Giraldo E, Martos F, Gomez A, Garcia A, Vigano MA, Ladinsky H, Sanchez de La Cuesta F.

Life Sci. 1988;43(19):1507-15.

PMID:
3193843

Supplemental Content

Loading ...
Support Center